Australia Developmental Anomalities Research

Major Players: GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Newron Pharmaceuticals SPA, F. Hoffmann-La Roche Ltd , AbbVie Inc.

Major Players: Boehringer Ingelheim International GmbH, UCB SA, Novartis AG, Teva Pharmaceutical, Merck & Co Inc.

Major Players: Biogen Inc., Novartis AG, Merck KGaA, Sanofi S. A., Acorda Therapeutics, Inc.

Major Players: Bayer AG, Nestle Health Science, Sanofi S.A. , Haleon Group of Companies, Novartis AG, Zydus Life Sciences Limited, Eli Lilly and Company

Major Players: Grünenthal, Mallinckrodt Pharmaceuticals, Pfizer, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.

Major Players: DJO Global, Inc. , Teikoku Pharma USA, Inc, Zimmer Biomet , 3M, AKSIGEN

Major Players: Novartis AG, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Zimmer Biomet, Viatris Inc.

Major Players: Medtronic Plc, Piramal Enterprises Ltd, Allergan plc, Ipsen, F. Hoffmann-La Roche Ltd

Major Players: Novartis AG, Bausch Health Companies Inc., REGENXBIO Inc., F Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc.

Major Players: Biogen, F. Hoffmann - La Roche Ltd , Cytokinetics, Inc., , Novartis AG, Catalyst Pharmaceutical

Major Players: Mitsubishi Tanabe Pharma Corporation, CORESTEM, Inc, BrainStorm Cell Limited, Amylyx Pharmaceuticals Inc., Biogen

Major Players: Ipsen Biopharmaceuticals Inc., Merz GmbH & Co. KGaA, Teva Pharmaceutical Industries Ltd., Supernus Pharmaceuticals, Inc., Abbvie Inc.